International Journal of Gastroenterology and Hepatology (ISSN: 2995-2301) | Volume 3, Issue 1 | Case Report | Open Access DOI
Zandirad E*
Zandirad E1*, Sgroi A1,3, Zufferey G1, Chatelain V2
1Department of Surgery, Division of Digestive Surgery, Nyon Hospital, Switzerland
2Department of Oncology, Nyon Hospital, Switzerland
3Department of Surgery, Vallee de Joux Hospital, Switzerland
*Correspondence to: Zandirad E
Fulltext PDFTesticular cancer is the most common neoplasia in young males. For seminoma, 80% are diagnosed with clinical stage I disease and presents excellent survival rate (>99%) with appropriate management plan [1]. Orchiectomy represents the standard of care, with surveillance in low- risk patient (0 or 1 factor) and surveillance versus adjuvant therapy (Carboplatin AUC 7 or 20-30 Gy if chemotherapy not achievable) according to higher-risk patient (both rete testis infiltration and lesion size > 4 cm) [2,3]. Metastases usually concerns retroperitoneal lymph nodes via lymphatic system and lungs, liver and bones via hematogenous spread. Gastric involvement is rare [4]. Late relapse (> 3 years) of clinical stage 1 seminoma is very rare with 0.2% patients only and chemotherapy (+/- surgery) appears to be the treatment of choice [5,6]. In clinical stage 1 non-seminoma testicular tumor, lymphovascular infiltration increases risk of recurrence and vascular invasion alone is considered the most important predictor of relapse and stratifies into low-risk (surveillance) or high-risk (adjuvant chemotherapy with one cycle of BEP) [7].
Cancer; Young males
Zandirad E, Sgroi A, Zufferey G, Chatelain V.Late Relapse of Testicular Seminoma Revealed by Gastric Metastasis: A Rare Case. Int Jour Gastro Hepat. 2024;3(1):1-4.